The EU’s €50.5 billion ($69.4 billion) research framework is the biggest such fund in the world. But it is not known for being nimble, and it is underused by European businesses. Now, as the seven-year program approaches its half-time review, a change in the political lineup could lead to shifts in funding priorities that favor ambitious pan-European ideas.

See the entire story on Nature Medicine’s website [html] or as it appeared in print: [pdf]